Gyönös I, Agoston M, Kovács A, Szénási G, Vereckei A
EGIS Pharmaceuticals Ltd, Budapest, Hungary.
Cardiovasc Drugs Ther. 2001;15(3):233-40. doi: 10.1023/a:1011916306782.
Oxidative stress and lysosomal phospholipoidosis, which also might be partly attributed to free radicals induced by amiodarone (AM), may be involved in AM toxicity, which can be prevented by antioxidants. Our aim was to study if vitamin E (E) or silymarin (S), a lipid and a water-soluble antioxidant, modified the antiarrhythmic efficacy of AM in a rat reperfusion arrhythmia test. The following groups of male Sprague-Dawley rats (15 rats/group) were treated by gavage once a day for 4 weeks: 1. methylcellulose (MC, 0.4%), 2. sunflower seed oil (SSO), 3. AM, suspended in MC (30 mg/kg), 4. E, dissolved in SSO (100 mg/kg), 5. AM + E, 6. S, suspended in MC (80 mg/kg), 7. AM + S. The mean duration of ventricular tachycardia + fibrillation (MDVT + VF) and sinus rhythm (MDSR) the incidence of ventricular fibrillation (VF) and ventricular tachycardia (VT) and mortality were measured during a 10-min reperfusion after a 5-min coronary artery occlusion in anaesthetized rats. An arrhythmia score, representing the combined incidence and duration of different types of ventricular arrhythmia, was calculated. Compared with the MC group, MDSR was longer and MDVT + VF was shorter in all drug treated groups and in the SSO group. In the AM + E treated group MDSR was prolonged more and MDVT + VF was shortened more than in the AM, E or SSO groups. Compared with the MC group, the incidence of VF and mortality was similarly decreased in the SSO group and in most drug treated groups. No significant difference in the incidence of VT was found among all groups. The arrhythmia score was reduced by all drug treatments. Combined treatment with AM + E decreased arrhythmia score more than treatment with AM or SSO alone, but arrhythmia score was similar in the AM + E and E groups. In conclusion, both AM and antioxidant treatments alone or together resulted in a marked reduction of reperfusion arrhythmias in this model. SSO also exerted a moderate antiarrhythmic effect. Antioxidants administered together with AM did not attenuate and E might have even enhanced the antiarrhythmic effect of AM, therefore the combination of antioxidants with AM may be advantageous to reduce AM toxicity.
氧化应激和溶酶体磷脂沉积症(这也可能部分归因于胺碘酮(AM)诱导的自由基)可能与AM毒性有关,而抗氧化剂可以预防这种毒性。我们的目的是研究维生素E(E)或水飞蓟宾(S,一种脂溶性和水溶性抗氧化剂)在大鼠再灌注心律失常试验中是否会改变AM的抗心律失常疗效。将以下几组雄性Sprague-Dawley大鼠(每组15只)每天经口灌胃一次,持续4周:1. 甲基纤维素(MC,0.4%),2. 葵花籽油(SSO),3. 悬浮于MC中的AM(30 mg/kg),4. 溶于SSO中的E(100 mg/kg),5. AM + E,6. 悬浮于MC中的S(80 mg/kg),7. AM + S。在麻醉大鼠冠状动脉闭塞5分钟后的10分钟再灌注期间,测量室性心动过速+颤动的平均持续时间(MDVT + VF)和窦性心律(MDSR)、室颤(VF)和室性心动过速(VT)的发生率以及死亡率。计算代表不同类型室性心律失常的综合发生率和持续时间的心律失常评分。与MC组相比,所有药物治疗组和SSO组的MDSR更长,MDVT + VF更短。与AM、E或SSO组相比,AM + E治疗组的MDSR延长更多,MDVT + VF缩短更多。与MC组相比,SSO组以及大多数药物治疗组的VF发生率和死亡率同样降低。所有组之间VT发生率无显著差异。所有药物治疗均降低了心律失常评分。AM + E联合治疗比单独使用AM或SSO治疗更能降低心律失常评分,但AM + E组和E组的心律失常评分相似。总之,在该模型中,单独或联合使用AM和抗氧化剂治疗均导致再灌注心律失常显著减少。SSO也发挥了适度的抗心律失常作用。与AM一起给予抗氧化剂不会减弱,E甚至可能增强AM的抗心律失常作用,因此抗氧化剂与AM联合使用可能有利于降低AM毒性。